Cerapedics Closes $22MM Financing

Cerapedics completed a US $22MM financing. Proceeds will support continued launch of i-FACTOR™ Peptide Enhanced Bone Graft and a second Level I investigational device exemption (IDE) human clinical study.

The round was led by KCK Group, a family investment fund.

Cerapedics received FDA Premarket Approval in 2015 for use of i-FACTOR in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us